Inhibition of HIV-1 Nef-induced apoptosis of uninfected human blood cells by serine/threonine protein kinase inhibitors, fasudil hydrochloride and M3

FEBS Letters

Volumn 422, Issue 3, 1998, Pages 363-367

  Okada, Harue ^a   Takei, Ryouichi ^a,b   Tashiro, Masato ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

Author keywords

AIDS; Apoptosis; HIV 1; Nef; Protein kinase inhibitor

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; FAS ANTIGEN; FASUDIL; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR; N ACETYLTRYPTOPHYLVALYLALANYLASPARTALDEHYDE; NEF PROTEIN; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIGENS, CD95; APOPTOSIS; ENZYME INHIBITORS; FEASIBILITY STUDIES; GENE PRODUCTS, NEF; HIV-1; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, HIV; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032488964     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(98)00045-3     Document Type: Article

References (19)

1. Pitrak D.L., Tsai H.C., Mullane K.M., Sutton S.H., Stevens P. J. Clin. Invest. 98:1996;2714-2719.
2. Boudet F., Lecoeur H., Gougeon M.L. J. Immunol. 156:1996;2282-2293.
3. Gougeon M.-L., Lecoeur H., Dulioust A., Enouf M.L., Crouvoisier M., Goujard C., Debord T., Montagnier L. J. Immunol. 156:1996;3509-3520.
4. Ho D.D., Neuman A.U., Pereoson A.S., Chen W., Leonard J.M., Markowitz M. Nature. 373:1995;123-126.
5. Otake K., Fujii Y., Kakaya T., Nishino Y., Zhong Q., Fujinaga K., Kameoka M., Ohki K., Ikuta K. J. Immunol. 153:1994;5826-5837.
6. Fujii Y., Otake K., Tashiro M., Adachi A. FEBS Lett. 393:1996;93-96.
7. Fujii Y., Otake K., Tashiro M., Adachi A. FEBS Lett. 391:1996;105-108.
8. Okada H., Takei R., Tashiro M. FEBS Lett. 414:1997;603-606.
9. Okada H., Takei R., Tashiro M. FEBS Lett. 417:1997;61-64.
10. Asano T., Ikegaki I., Satoh S., Shibuya M., Takayasu M., Hidaka H. J. Pharmacol. Exp. 241:1987;1033-1040.
11. Enari M., Hug H., Nagata S. Nature. 375:1995;78-81.
12. Seto M., Sasaki Y., Sasaki Y., Hidaka H. Eur. J. Pharmacol. 195:1991;267-272.
13. Westendrop M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Nature. 375:1995;497-500.
14. Smith C.A., Farrah T., Goodwin R.G. Cell. 76:1994;959-962.
15. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.-P., Nicholl J.K., Sutherland G.R., Smith T.V., Rauch C., Smith C.A., Goodwin R.G. Immunity. 3:1995;673-682.
16. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., Dixit V.M. Science. 276:1997;111-113.
17. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Science. 277:1997;818-821.
18. Shibuya M., Suzuki T., Sugita K., Saito I., Sasaki T., Takakura K., Nagata I., Kikuchi H., Takemae T., Hidaka H., Nakashima M. J. Neurosurg. 76:1992;571-577.
19. Sato, T., Asamitsu, K., Yang, J.-P., Takahashi, N., Tetsuka, T., Yoneyama, A., Kanagawa, A. and Okamoto, T. AIDS Res. Hum. Retroviruses, in press.